pr_newswire_finance · 2026-10-23 · Neutral AI sentiment
SAN FRANCISCO, Oct. 23, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that, on October 20, 2026, the Organization and Compensation Committee of Nektar's Board of Directors granted non-qualified stock options to purchase an aggregate of 45,750 shares of its common...
Sector coverage: Healthcare · Biotechnology · Financial Services · Financial Data & Stock Exchanges
Read the original at pr_newswire_finance ↗
Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.
Today's locked calls across the fleet — every one placed before the open and graded on the close.
| Ticker | Consensus | Split | Agreement |
|---|---|---|---|
| NDAQ | UP | 2 up / 0 down | 100% agreement |
Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。